A Peptide Mimetic Targeting Trans-Homophilic NCAM Binding Sites Promotes Spatial Learning and Neural Plasticity in the Hippocampus by Kraev, Igor et al.
A Peptide Mimetic Targeting Trans-Homophilic NCAM
Binding Sites Promotes Spatial Learning and Neural
Plasticity in the Hippocampus
Igor Kraev
1., Christian Henneberger
2., Clara Rossetti
3., Lisa Conboy
3., Lene B. Kohler
4, Martina
Fantin
3, Alistair Jennings
2, Cesar Venero
5, Victor Popov
1, Dmitri Rusakov
2, Michael G. Stewart
1*,
Elisabeth Bock
4, Vladimir Berezin
4, Carmen Sandi
3*
1Department of Life Sciences, The Open University, Milton Keynes, United Kingdom, 2Department of Clinical and Experimental Epilepsy, Institute of Neurology,
University College London (UCL), London, United Kingdom, 3Laboratory of Behavioral Genetics, Brain Mind Institute, EPFL, Lausanne, Switzerland, 4Protein Laboratory,
Department of Neuroscience and Pharmacology, Panum Institute, University of Copenhagen, Copenhagen, Denmark, 5Department of Psychobiology, UNED, Ciudad
Universitaria, Madrid, Spain
Abstract
The key roles played by the neural cell adhesion molecule (NCAM) in plasticity and cognition underscore this membrane
protein as a relevant target to develop cognitive-enhancing drugs. However, NCAM is a structurally and functionally
complex molecule with multiple domains engaged in a variety of actions, which raise the question as to which NCAM
fragment should be targeted. Synthetic NCAM mimetic peptides that mimic NCAM sequences relevant to specific
interactions allow identification of the most promising targets within NCAM. Recently, a decapeptide ligand of NCAM—
plannexin, which mimics a homophilic trans-binding site in Ig2 and binds to Ig3—was developed as a tool for studying
NCAM’s trans-interactions. In this study, we investigated plannexin’s ability to affect neural plasticity and memory formation.
We found that plannexin facilitates neurite outgrowth in primary hippocampal neuronal cultures and improves spatial
learning in rats, both under basal conditions and under conditions involving a deficit in a key plasticity-promoting
posttranslational modification of NCAM, its polysialylation. We also found that plannexin enhances excitatory synaptic
transmission in hippocampal area CA1, where it also increases the number of mushroom spines and the synaptic expression
of the AMPAR subunits GluA1 and GluA2. Altogether, these findings provide compelling evidence that plannexin is an
important facilitator of synaptic functional, structural and molecular plasticity in the hippocampal CA1 region, highlighting
the fragment in NCAM’s Ig3 module where plannexin binds as a novel target for the development of cognition-enhancing
drugs.
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Introduction
Neural cell adhesion molecule (NCAM), a prominent protein of
the immunoglobulin (Ig) superfamily, plays a key role in neural
development and synaptic plasticity. NCAM is expressed as three
major isoforms with molecular weights of 180, 140 and 120 kDa.
Extracellularly, all NCAM isoforms contain five Ig domains and
two fibronectin type 3 (F3) domains [1]. The mechanisms by
which NCAM affects neural plasticity include activation of
intracellular signaling cascades and regulation of cell–cell and
cell–extracellular matrix adhesion and de-adhesion [2]. De-
adhesion processes are mediated largely by the addition of long
sialic acid residues (polysialic acid, PSA) to NCAM’s Ig5 domain
[3], whereas adhesion processes involve both homophilic and
heterophilic interactions of NCAM [4].
A key role for NCAM in memory formation has been
established through animal studies showing that NCAM expres-
sion transiently increases in the hippocampus after training in
spatial or contextual tasks [5,6]. Interfering with the function
or expression of NCAM through pharmacological or genetic
approaches impairs memory function and long-term potentiation
[7–10]. This evidence implicates NCAM as a particularly relevant
target for the development of cognition-enhancing drugs. Given
NCAM’s structural and functional complexity it is critical to first
identify the most promising target within NCAM. This has
recently been achieved by developing synthetic NCAM mimetic
peptides that mimic NCAM sequences relevant to specific
interactions based on combinatorial chemistry and structural
studies [4]. Mimicking NCAM’s interaction with the fibroblast
growth factor receptor (FGFR) through the pentadecapeptide
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NCAM, has been very successful in improving cognition [11,12].
FGL can affect behavior in the absence of NCAM [13].
The crystal structure of an NCAM fragment combining the first
three Ig modules revealed NCAM’s homophilic binding mecha-
nisms. The pattern of specific interactions between these Ig
modules indicated that Ig1 and Ig2 mediate dimerization of
NCAM molecules expressed on the same cell surface (cis-
interactions), whereas Ig3 mediates interactions between NCAM
molecules on the surfaces of opposing cells (trans-interactions) by
simultaneously binding to Ig1 and Ig2 [14]. Although the cognitive
effects of tackling NCAM cis-interactions have already been
reported [15], the effects of mimicking NCAM trans-interactions
remain unexplored. Recently, a decapeptide ligand of NCAM—
plannexin, which mimics a homophilic trans-binding site in Ig2
and binds to Ig3— was developed as a tool for studying NCAM’s
trans-interactions [16]. This peptide promotes neurite growth and
cell survival in vitro. Here, we have found that plannexin promotes
neurite outgrowth in hippocampal cell cultures and spatial
learning both under normal conditions and under PSA deficiency.
Plannexin also facilitated synaptic transmission in the CA1
hippocampal region. Moreover, an increase in the density of
mushroom-like dendritic spines and in the synaptic incorporation
of AMPA glutamate receptors was observed in CA1.
Materials and Methods
Ethics Statement
All procedures were conducted in accordance with the Swiss
National Institutional Guidelines of Animal Experimentation and
were approved by the Swiss Cantonal Veterinary Office Committee
for Animal Experimentation (Licenses number 1647.1 and 1747.4).
Peptides
The plannexin peptide (DVRRGIKKTD) consists of a combi-
nation of sequences from the CD (three amino acids) and EF loops
(seven amino acids) of the NCAM Ig2 module that, according to the
crystal structure, are involved in homophilic contact with the Ig3
module [16]. The name plannexin is given to the peptide because it
is derived from the binding site in the NCAM Ig2 module where it
binds to the NCAM Ig3 module in trans-homophilic interactions of
two NCAM molecules in the so-called flat (plane) zipper formation.
Theidentificationofthepeptide(withthisname)hasbeenpublished
previous [16]. Plannexin and a corresponding scrambled peptide
(KTKVDRDGRI) were purchased from Schafer-N (Copenhagen
Denmark). The peptides were synthesized as tetrameric dendrimers
(plannexin-d) composed of four monomers coupled to a three-
lysine-containing backbone. The peptides were dissolved in sterile
distilled water or CSF. The concentrations of the peptides were
measured spectrophotometrically by absorption at 205 nm.
Materials for cell culture
Endoneuraminidase-N (EndoN) was a kind gift from Prof. Rita
Gerardy-Schahn (Hannover, Germany). Polyclonal rabbit anti-
GAP-43 antibodies were obtained from Chemicon (Temecula, CA,
USA). Monoclonal anti-PSA-NCAM mouse antibody was obtained
from AbCys S.A. (Paris, France) Alexa Fluor 488 polyclonal goat
anti-rabbit and Alexa Fluor goat anti mouse 547 antibodies were
obtained from Molecular Probes (Eugene, OR, USA). Neuroba-
salTM medium, basal modified Eagle’s (BME) medium, fetal calf
serum (FCS), penicillin, streptomycin, B27 supplement, glutamax,
Na-pyruvate, and HEPES were purchased from Gibco BRL
(Paisley, UK). Trypsin, DNAse 1, soybean trypsin inhibitor, bovine
serum albumin (BSA), cytosine b-D-arabino-furanoside (AraC) and
poly-L-lysine (PLL) were from Sigma-Aldrich Denmark A/S
(Copenhagen, Denmark). Antifade fluorescence mounting medium
was from Dako (Glostrup, Denmark). All tissue culture plastic was
obtained from NUNC (Roskilde, Denmark).
Cell cultures
Cells were routinely incubated at 37uC in a humidified
atmosphere containing 5% CO2. Cerebellar granule neurons
(CGNs) were obtained from postnatal day 3 Wistar rat pups
(Charles River, Sulzfeld, Germany) essentially as previously
described by Schousboe et al. [17]. Briefly, after dissection, the
cerebella were cleared of blood vessels and meninges, crudely
homogenized by chopping before trypsin treatment, and washed
in the presence of DNase and trypsin inhibitor. Cellular debris was
then pelleted by centrifugation. The CGNs were plated in
Neurobasal medium supplemented with 0.4% w/v BSA, 2% v/v
B27, 20 mM HEPES, 1% v/v glutamax, 100 U/ml penicillin, and
100 mg/ml streptomycin. Hippocampal neurons were obtained
from embryonic day 19 (E19) Wistar rat embryos (Charles River
Laboratories, Sulzfeld, Germany). The embryos were decapitated,
and the brains were removed. Hippocampi were dissected and
cleared of membranes and blood vessels in ice-cold modified
Krebs-Ringer buffer. Cultures of single neurons were prepared as
described above for CGNs.
Neurite outgrowth assay
Dissociated neurons were plated at a density of 12,500 cells/cm
2
directly on plastic in eight-well Permanox Lab-Tek chamber slides
in Neurobasal
TM medium supplemented as described above with or
without peptides. For enzymatic removal of PSA from NCAM,
cultures weretreatedwith 15 nM(CGNs)and30 nM(hippocampal
neurons) of the enzyme endoneuraminidase (EndoN). Twenty-four
hours later, the cells were fixed and immunostained for GAP-43 to
visualize the neurons. Images of at least 200 cells were captured for
each group in each individual experiment in a systematic series of
fields of view as previously described [18] by computer-assisted
fluorescence microscopy using a Nikon plan 206objective (Nikon,
Tokyo, Japan) and a videocamera(Grundig Electronics,Germany).
The average neurite length per cell was estimated using a
stereological approach [18] and the Prima software package
developed at the Protein Laboratory (Copenhagen, Denmark).
Subjects
Rats and mice were used throughout the study. The rats were
male Sprague-Dawleys (Charles River, France) weighing 275–300 g
upon arrival. Wild-type (WT) mice or knock-out (KO) mice for the
polysialyltransferase (PST; ST8SiaIV) gene (PST KO) were used.
Experiments always included age-matched WT littermates (between
4 and 8 months old at the onset of behavioral testing). These animals
were obtained from our animal house by intercrossing heterozygous
mice to obtain homozygous KO mice and WT littermates. All mice
originated from different PST breeding couples, which had been
previously backcrossed for more than 10 generations into the
C57BL/6J background. All animals were housed in groups of three
per cage under light- (12 h/12 h light/dark cycle; lights on at 07:00
h) and temperature- (2262uC) controlled conditions. Food and
water were available ad libitum. Behavioral experiments were
conducted between 09:00 h and 14:30 h.
Genotyping
All mice were genotyped before and after behavioral testing by
polymerase chain reaction (PCR). Tail DNA was extracted with a
GenScript TissueDirect Multiplex PCR System (GenScript
NCAM and Cognition Enhancement
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buffer containing 1.0 U/50 ml Taq DNA Polymerase, 45 mM
KCl, 2.5 mM Mg2+, 200 mM dNTP (Eppendorf Hotmastermix,
Eppendorf AG, Hamburg, Germany) and 0.4 mM of the
corresponding primers (for PST, the forward primer for WT
and KO mice was 5_-GAG CTC ACA ACG ACT CTC CGA
GC-3 and the reverse primers were 5_-CTC AGT TCT GGC
TAT TTC TTT TGT-3_ and 5_-ACC GCG AGG CGG TTT
TCT CCG GC-3, respectively. The cycling conditions for the
PST PCR were 95uC for 3 min, 56uC for 1 min and 72uC for
2 min for the first cycle. This was followed by 35 cycles at 95uC for
1 min, 56uC for 1 min and 72uC for 2 min, with a final extension
at 72uC for 10 min. PCR products were resolved on a 2% agarose
gel to determine genotypes (PST was 533 bp for WT and 730 bp
for KO).
Field potential recordings
Acute 350-mm-thick hippocampal slices from three- to four-
week-old male Sprague-Dawley rats were transferred to a
recording chamber (Scientific Systems Design, NJ), superfused
with (mM) 119 NaCl, 2.5 KCl, 2 CaCl2, 1.3 MgSO4,2 6
NaHCO3, 1 NaH2PO4, and 10 glucose at room temperature and
bubbled with 95% O2/5% CO2. The slice cutting procedure has
been previously described in detail [19]. Field potentials (fEPSPs)
were recorded through glass electrodes filled with bath solution
positioned either in the stratum moleculare of the dentate gyrus or
in the stratum radiatum of the CA1 area. Field responses were
evoked by electrical stimulation of the perforant pathway or
Schaffer collaterals using mono- or bipolar stimulation electrodes
(100 ms, 10–120 mA). They were then recorded (Multiclamp 700B,
Molecular Devices, Sunnyvale, U.S.A.), sampled (National
Instruments, Austin, U.S.A.) and stored for off-line analysis
(WinWCP, John Dempster, University of Strathclyde, UK).
Responses were elicited every 30 sec. Baseline responses were
recorded for at least 10 min before plannexin or its scrambled
variant were bath-applied for 30 min followed by a wash-out
period. The initial slope of the fEPSPs was analyzed.
Spatial learning in the water maze
The water maze was a circular pool. For rat experiments, the
pool was black (2 m diameter, 45 cm high) and filled with normal
water (30 cm depth). For mouse experiments, the pool was white
(140 cm diameter) and filled with opaque colored water. The
water temperature in all experiments was set at 2561uC. An
invisible escape platform (11 cm diameter for rats and 10610 cm
for mice) was placed at a fixed location equidistant from the
sidewall and the middle of the pool and submerged 1.3 cm (mice)
or 1.5 cm (rats) below the water’s surface. The respective water
mazes were surrounded by grey curtains placed at least 25 cm
from the pool’s periphery. The curtains had several prominent
visual cues. Behavior was monitored by a video camera mounted
in the ceiling above the center of the pool. The camera was
connected to a computerized video tracking system (Ethovision
3.1.16, Noldus IT, Wageningen, The Netherlands). Mice were
habituated to the room, apparatus, and water by giving them a
1 min free-swim trial one day before training. Spatial learning
sessions were conducted on 3 consecutive days (days 1–3) with 4
trials per day. Each trial started by introducing the animal into the
maze at one of 4 possible positions that were randomly balanced
between trials and days. The latency and cumulative distance that
animals needed to swim to find the hidden platform were
measured. If an animal did not find the platform within 90 sec
(rats) or 60 sec (mice), it was gently guided toward it. Each animal
was allowed to remain on the platform for 30 sec before it was
returned to its waiting cage. After the last trial in each session, the
animals were first carefully dried with a towel and then placed in a
waiting cage heated to 32uC for 10 min. The animals were then
returned to their home cages. On day 4, a 60 sec probe test with
no platform present was performed. The animals were given drug
treatments immediately after water maze training on days 1 and 2.
Since animals were only started to be treated after training on day
1, data for water maze training is analyzed and represented
starting on day 2.
Acoustic fear conditioning
Rat training and testing took place in three identical rodent
observation cages (30637625 cm) placed in a sound-attenuating
chamber illuminated by a 20 W bulb. The side walls of the
observation cages were constructed of stainless steel, and the door
was Plexiglas. The floor consisted of 20 steel rods wired to a shock
source and a solid-state scrambler for the delivery of footshock
unconditioned stimuli (US). Ventilation fans provided a back-
ground noise of 68 dB (whole system: Panlab, Spain). The animals
were transported from the colony room to the adjacent fear-
conditioning room where training and testing occurred. For
training, rats were exposed to Context A (black walls of smooth
texture, steel grid floor cleaned with 2% ethanol) for 160 s,
followed by three presentations of tone-shock pairings in which the
tone (20 s, 80 dB sound at 1000 Hz) co-terminated with a foot
shock (0.4 mA, 1 s). The inter-tone interval was 40 s, and the
conditioning session lasted 5.5 min in total. In the tone memory
test (performed 24 h after the AFC session), rats were put into
Context B (green walls of rough texture, grey plastic floor covered
with flocks cleaned with 1% acetic acid) for 8 min in total and
confronted with the same tone used in training during the last
5 min. Freezing, defined as behavioral immobility except for
respiratory movements, was scored every 30 s and transformed
into a percentage value. Animals were treated with the peptide
plannexin or vehicle immediately after the ACF training session.
Elevated plus maze, open field and novel object
reactivity
To study the effects of drug treatment on anxiety-like behaviors
and on exploratory activity, we tested rats in the open field (10 min),
and 2 h later, we tested them in the elevated plus maze (EPM) for
5 min. Rats received two plannexin injections (2.5 mg/5 ml) on the
two days preceding the behavioral test day (one injection/day). In
alltests, behaviorwas monitoredusinga videocameraand analyzed
with a computerized tracking system (Ethovision 3.1.16, Noldus IT,
The Netherlands).
Anxiety-related behaviors were evaluated using the EPM test
[20]. Briefly, the plus maze consists of two opposing open arms
(45610 cm) and two enclosed arms (45610638 cm) that extend
from a central platform (10610 cm) elevated 50 cm above the
ground. Light was adjusted to levels of 10–12 lx in the center of the
maze. The rats were placed individually on the central platform
and allowed to explore the maze for 5 min. Time spent in the
open and closed arms was recorded. Anxiety was assessed as the
time spent in the open arms.
Exploratory activity was tested in the open field test. The open-
field consisted of a black pool with a diameter of 1 m and a depth
of 40 cm. The floor of the pool was divided into three zones: an
outer zone with a diameter of 1 m, an inner zone with a diameter
of 75 cm, and a center zone with a diameter of 25 cm. Light was
adjusted to a level of 8–10 lx in the center of the pool. Animals
were placed in the center of the pool and their open-field activity
was recorded for 10 min.
NCAM and Cognition Enhancement
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placement
The rats and mice underwent surgery for i.c.v. cannulation.
They were anesthetized intraperitoneally with xylazine (10 mg/kg)
and ketamine (80 mg/kg). A 22-gauge (rats) or 26-gauge (mice)
metal guide cannula (Plastics One, Roanoke, VA, USA) fitted with
a removable dummy cannula was stereotactically implanted above
the right lateral cerebral ventricle (rats: 1.0 mm posterior, 1.5 mm
lateral from bregma, and 4.3 mm ventral from the skull surface;
mice: 0.36 mm posterior, 1.0 mm lateral from bregma and
2.0 mm ventral from the skull surface). The coordinates were
based on the atlases of Paxinos and Watson [21] (rats) and Paxinos
and Franklin (mice). The cannula was fixed to the skull with a
cyanoacrylate adhesive (Vetbond, 3M, St. Paul, Minnesota, USA)
and dental cement (Paladur, Hereaus-Kulzer). After surgery, the
animals were housed individually and allowed at least 1 week to
recover from the surgery. For i.c.v. injections, the dummy cannula
was removed and replaced with an infusion cannula (Plastics One)
0.5 mm longer than the guide cannula and attached to a 10 ml
Hamilton syringe via polyethylene tubing. A total volume of 5 ml
(rats) or 1 ml (mice) of solution was injected with a micro-injection
pump (Harvard apparatus, Cambridge, MA) with an infusion rate
of 1–0.25 ml/min. The infusion cannula was left in place for an
additional 2 min to allow for diffusion. Plannexin and the
scrambled peptide were i.c.v. infused, both in rats and mice, at
a dose of 2.5 mg/animal that was chosen based on the in vitro data
and our experience finding the corresponding effective dose for in
vivo application accumulated with other NCAM-derived memory
enhancing peptides derived [11,15]. The peptide concentration
delivered in a 5 ml volume was 97 mM (i.e., 0.485 nmol).The PSA-
cleaving enzyme EndoN was administered to rats at a dose of
0.25 U/injection 24 h before the start of water maze training.
Peptides and EndoN were diluted in sterilized artificial cerebro-
spinal fluid (CSF), pH 7.4. Solutions were freshly prepared before
injection.
Following the behavioral tests, the animals were anesthetized
with sodium pentobarbital (50 mg/kg, i.p.). A cresyl violet solution
was administered following the same protocol as for the drug
injections. After decapitation, brains were removed and examined
for the presence of cresyl violet. Only animals with a correctly
placed cannula were included in the analyses.
Immunocytochemistry
To verify the effectiveness of EndoN treatment, rats injected
with plannexin and vehicle were deeply anesthetized with sodium
pentobarbital and transcardially perfused with 100 ml of phos-
phate-buffered saline (PBS; pH=7.4) followed by 250 ml of 4%
paraformaldehyde in 0.1 M phosphate buffer. Brains were
postfixed in the same fixative solution for 4 h. Coronal sections
(50 mm thick) were cut on a vibratome (Leica VT 1000S;
Glattbrugg, Switzerland) and collected in PBS. Briefly, brain
sections were pre-washed in PBS (three times for 10 min each) and
incubated with 3% H2O2 in PBS for 10 min to block endogenous
peroxidase activity. After being washed in PBS, the sections were
treated for 1 h with 10% normal donkey serum (NDS, Jackson
ImmunoResearch Laboratories, Basel, Switzerland) and 0.2%
Triton X-100 (Sigma, Buchs, Switzerland) in PBS. After being
washed in PBS, they were incubated for 48 h at 4uC with
monoclonal mouse anti-Men PSA-NCAM antibody (AbC0019;
Abcys, Paris, France) at a dilution of 1:1500. PBS containing 0.2%
Triton-X-100 and 5% NDS was used for primary and secondary
antibody dilutions. After washing in PBS, the sections were
incubated for 1 h at room temperature (RT) with a biotin-SP-
conjugated donkey anti-mouse immunoglobulin M (IgM) (Jackson
ImmunoResearch Laboratories, Basel, Switzerland) at a 1:200
dilution. Finally, a 1:300 dilution of streptavidin-horseradish
peroxidase conjugate (GE Healthcare UK Limited, Zurich,
Switzerland) was added and incubated for 1 h at RT. PSA-
NCAM antibody-peroxidase complexes were visualized using
0.5 mg/ml diaminobenzidine (DAB; Sigma- Aldrich, Basel,
Switzerland) and 0.01% H2O2 in PBS. The sections were mounted
on superfrost slides, dehydrated with an ethanol series, and
coverslipped with DPX (Sigma-Aldrich, Basel, Switzerland). For
the quantification of PSA-NCAM immunoreactivity, 5 coronal
hippocampal sections from each rat (taken between 3.55 and
3.8 mm posterior to bregma) were processed. The total number of
PSA-NCAM immunoreactive cells in the dentate gyrus of each
slice was manually counted in both hemispheres under a
microscope with a 406objective.
For immunohistochemical characterization in electron micros-
copy experiments, the 50-mm hippocampal sections were blocked
in incubation buffer for 2 hours, followed by incubation in
primary antibody (mouse anti-PSD-95, 1:400 and rabbit anti-
PSD-93, 1:200) in incubation buffer overnight at 4uC. After being
rinsed in PBS, the sections were incubated in secondary antibody
(donkey anti-rabbit, 1:100 and donkey anti-mouse, 1:100) in
incubation buffer for 4 h at RT. After another set of washes, ABC
Elite reagent (Vector Laboratories, UK) was applied for 1 h.
As substrate for the peroxidase reaction, diaminobenzedine
(DAB, Sigma, USA) was applied for 5 min at a concentration
of 0.22 mg/ml in Tris buffer (pH 7.4) with 0.01% hydrogen
peroxide. The sections were thoroughly washed and prepared for
electron microscopy.
Electron Microscopy
Rats were anesthetized with pentobarbital and transcardially
perfused with 3.75% acrolein/2% paraformaldehyde (in 0.1 M
phosphate buffer) following water maze training; more precisely,
on day 4, after submitting animals to the probe trial. The
hippocampi were then coronally sectioned with a vibratome at
50 um and processed for electron microscopy as described
previously (1). Ultrathin serial sections were taken from the
stratum radiatum of area CA1 of the hippocampus, stained, and
examined in a JEOL 1010 electron microscope. Electron
micrographs were taken at 60006magnification. Cross-sectioned
myelinated axons, dendrites, and mitochondria spanning all
sections provided a fiduciary reference for the initial alignment
of serial sections. Section thickness was determined using the
approach of Fiala and Harris (http://synapse-web.org). For digital
reconstructive analyses, digitally scanned EM negatives were
aligned as JPEG images (software available from Fiala and Harris:
http://synapses.clm.utexas.edu/tools/index.stm) and contours of
individual cells, and their elements were traced digitally and
computed.
Stereological estimates of synapse density in the stratum
radiatum of CA1 area were made 90–110 mm from the proximal
edge of the CA1 pyramidal cell layer. Stereological analyses were
performed as previously described [22,23] on tissue volumes of
approximately 500–800 mm3. Synapses were identified via
postsynaptic densities (PSDs) and the presence of at least two
presynaptic vesicles). The synapses were then categorized
according to [24,25]. A spine is classified as a mushroom if its head
is significantly wider than the width of its neck; as thin if its length is
greater than the width of its neck and head; and stubby, if the width
of the neck is similar to its length. Generally, the volume of a thin
spine is approximately 10 times less than that of a mushroom
spine.
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tive of the presence of components such as large dendrites and
non-spiny dendrites of interneurons, in order to avoid bias in the
data obtained. Synaptic densities were expressed as number of
synapses per 100 mm3 of tissue.
Preparation of hippocampal homogenates and
synaptoneurosomes
Synaptoneurosomes (SNS) were prepared according to the
method described by Quinlan et al. [26] and Conboy and Sandi
[27]. Briefly, the CA1 area of the hippocampus was homogenized
in ice-cold homogenization buffer (10 mM HEPES/1.0 mM
EDTA/2.0 mM EGTA/0.5 mM DTT/0.1 mM PMSF) contain-
ing a protease and phosphatase inhibitor cocktail (Roche,
Switzerland). The homogenates were then passed through two
100-mm-pore nylon mesh filters. At this stage, aliquots of whole
hippocampus were taken, solubilized with 1% NP-40, and stored
at 280uC for future analyses. The remaining tissue was filtered
twice through 5-mm-pore filters. Filtered homogenates were
centrifuged at 36006 g for 10 min at 4uC. The resultant pellets
were re-suspended in 100 mL 1% SDS, boiled for 10 min, and
stored at 280uC.
Quantification of FGFR1 phosphorylation
Phosphorylation of FGFR1 was quantified in hippocampal
homogenates by an enzyme-linked immunoabsorbent assay
(ELISA). In brief, flat-bottom 96-well microplates were allowed
to adsorb a coating solution (Na2CO3 0.1 M/NaHCO3, 0.1 M)
for 2 h at RT. The solution was removed, and 50 ml of pellet
sample was added at a concentration of 10 mg/ml to each well of
the polystyrene flat-bottom ELISA plate. Plates were incubated
overnight at 4uC and then washed three times with 0.03 M PBS
containing 0.05% Tween 20, pH 7.4. Additional binding sites
were blocked with BSA (3%) for 2 h at RT. The wells were rinsed
three times as described above and incubated with 50 ml aliquots
of polyclonal rabbit anti-FGFR1 phosphospecific antibody (1:100,
Biosource International, Inc. USA) for 20–24 h at 4uC. Then, the
wells were washed, and 50 ml aliquots of anti-rabbit IgG
peroxidase conjugate (whole molecule conjugate; 1:500; Sigma,
Spain) were added for 2 h. Subsequently, 50 ml of citrate buffer
(50 mM Na2HPO4, 25 mM citric acid, pH 4.5) containing 1 mg/ml
o-phenylene diamine and 0.06% H2O2, added just before use was
placed in each well. The peroxidase was allowed to react for 10 min
at RT. The reaction was terminated by the addition of 50 mlo f5N
H2SO4 to each well. The optical density was determined by
measuring absorbance at 492 nm with a Microplate Reader
(DigiScan Reader V3.0 and DigiWIN software Program; ASYS
Hitech GmbH, Austria).
Quantitative western blotting
Protein content in whole and synaptoneurosome hippocampal
samples was quantified using the DC protein assay (Biorad
Laboratories AG, Switzerland). Quantitative western blotting was
carried out as previously described [23]. Briefly, equal protein
samples were prepared at a concentration of 0.5 mg/ml in 33 mM
NaCl, 70 mM Tris-HCl, 1 mM EDTA, 2% (w/v) SDS, 0.01%
(w/v) bromophenol blue, 10% glycerol, pH 6.8. Proteins were
resolved on 10% polyacrylamide gels and transferred to
nitrocellulose membranes. Antibodies against GluA1 (1:10000,
Assay Design, MI), GluA2 (1:2000, AbCAM, UK), GluA3 (1:1000,
Invitrogen AG, Switzerland), NR1 (1:10000, Millipore, Switzer-
land) and actin (1:20000, Sigma-Aldrich, Switzerland) were
applied and detected within the linear range of detection.
Immunoreactive bands were detected using the Biorad ChemiDoc
XRS system. Densitometric analysis was calculated using Biorad
Quantity One (4.2.3) software (Biorad Laboratories AG, Switzer-
land). The absorbance for each of the synaptic protein antibodies
was normalized to within-lane actin absorbance. Average den-
sitometric data are reported for plannexin as a percentage of the
vehicle control values.
Statistics
Statistical analyses were performed using GraphPad Prism
v5.03 (GraphPad, San Diego, CA, USA) and SPSS, and they
involved a preliminary assessment of data normality with the
D’Agostino-Pearson test. When normality was confirmed, the data
were analyzed with either Student’s t-test or ANOVA (either
factorial, one-way or repeated measures) followed by Newman-
Keuls or the Bonferroni post hoc test, when appropriate. When
normality was rejected, the data were analyzed using the
nonparametric Mann-Whitney U test. Significance was set at
p,0.05.
Results
Plannexin induces neurite outgrowth in primary
neuronal cultures that is independent of PSA expression
We recently identified a peptide agonist of NCAM termed
plannexin. Plannexin consists of a discontinuous sequence in the
second NCAM Ig module that is predominantly located on one
side of the C-terminal part of the module involved in homophilic
trans-interactions [16] (Figure 1). Thus, plannexin is a synthetic
compound that mimics a natural peptide sequence in NCAM.
Plannexin has been shown to be a potent inducer of
neuritogenesis in primary CGNs [16]. Because primary neurons
obtained from both CGNs and hippocampal neurons express
highly polysialylated NCAM [28] (Fig. 2a], we investigated
Figure 1. Localization of the plannexin sequence in the NCAM
Ig module. A space-filling model of Ig2 with two 180u rotation
projections (margenta) is shown (PDB 1QZ1). The sequence of
plannexin is mapped in yellow. The figure was made using PyMOL
Molecular Viewer (DeLano Scientific LLC. San Francisco, CA, USA).
doi:10.1371/journal.pone.0023433.g001
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polysialylation. PSA is a long, linear homopolymer of a-2,8-linked
sialic acid. In vertebrates, PSA is added to the fifth Ig module of
NCAM by two polysialyltransferases, ST8SiaII and ST8SiaIV.
The PSA moiety is highly hydrated, and its enormous excluded
volume is known to modulate NCAM-mediated adhesion and
plasticity [29]. Hippocampal neurons (Fig. 2b) and CGNs (Fig. 2c)
were treated for 24 h with plannexin. The cultures were fixed and
immunostained for GAP-43, and neurite outgrowth was analyzed.
Plannexin induced prominent neurite outgrowth in both types of
primary neurons (hippocampal, Fig. 2b: F3,16=79.4; P,0.0001;
CGNs, Fig. 2c: F3,12=290.7; P,0.0001). Next PSA was removed
from NCAM by treating cultures with plannexin and EndoN in
parallel. Plannexin’s neuritogenic effects persisted in the presence
of EndoN and thus do not depend on NCAM polysialylation.
Plannexin enhances excitatory transmission in
hippocampal area CA1
Because plannexin affected neuronal connectivity in culture, we
next asked if plannexin could modify synaptic transmission in situ
in the hippocampus (Figure 3). Indeed, bath application of
plannexin (10 mg/ml for 30 min; concentration: 1.94 mM) in-
creased the slope of fEPSPs evoked by Schaffer collateral
stimulation by 46.1611.4% (p,0.001, one-population Student’s
t-test, n=17, Figure 3A), and this effect was largely reversed
within ,30 min of washout. A scrambled version of plannexin did
not alter the fEPSP slope using the same protocol (Figure 3B,
+1.466.0%, n=5, P=0.83, one-population Student’s t-test).
However, plannexin had no significant effect on fEPSPs evoked
in dentate gyrus by perforant pathway stimulation (Figure 3C,
21.069.0%, n=8, P=0.91). This disparity could be explained by
a reportedly substantial difference in the polysialylation homeo-
stasis between the two areas (see Discussion). Our results indicate
therefore that plannexin couldacutely potentiate synaptic transmis-
sion in CA1 in a pathway-specific manner(whereas its scrambled
variant is ineffective; Figure 3D, scrambled vs. plannexin, P,0.01,
two-population unpaired Student’s t-test).
Plannexin improves spatial learning
In view of the facilitating effects of plannexin on synaptic
transmission in the hippocampus, we next addressed its potential
ability to influence spatial learning in vivo using the water maze
[30]. As in a previous study in which the NCAM mimetic peptide
FGL potentiated spatial memory [11], we evaluated the effect of
post-training administration of the synthetic peptide on the
learning and retrieval of this task. We trained rats for 3 consecutive
days in daily sessions involving 4 trials each. Immediately after
training on days 1 and 2, rats were injected i.c.v. with 2.5 mgo f
Figure 2. The effect of EndoN treatment on plannexin-induced neurite outgrowth and survival. (a) 125,000 cells/cm
2 CGNs were left to
differentiate for six days in the presence of high potassium (40 mM), followed by a 48 h incubation period with or without 15 nM EndoN. Cultures
were double immunostained for GAP-43 (green) and PSA-NCAM (red). 12,500 cells/cm
2 Hippocampal neurons (b) and CGNs (c) were grown for 24 h
in the presence or absence of 1.74 mM plannexin and treated with 30 nM EndoN (b) or 15 nM EndoN (c). Results from 4–5 experiments are expressed
as a percentage 6 SEM, with unstimulated controls set at 100%. ***p,0.001 vs. untreated controls;
+++p,0.001 vs. peptide-treated cultures without
EndoN treatment.
doi:10.1371/journal.pone.0023433.g002
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peptide, n=8; as no differences were found between vehicle- and
scramble peptide-injected rats, Figures 4C and 4D, their data were
collapsed into one control group). All groups exhibited similar
latencies to find the platform during the first training session (i.e.,
before any drug treatment was given; Figure 4A, day 1). Two-way
ANOVA of the animals’ cumulative distance from the platform on
days 2 and 3 revealed a main effect of treatment (Figure 4A;
F1,105=5.01, p,0.05) and of trial (F7,150=6.67, p,0.01), but not
a significant trial6treatment interaction (F7,105=0.86, n.s.). As
shown in Figure 4A, plannexin-treated rats showed shorter
cumulative distances to the platform than vehicle-treated rats
(F1,105=5.01, p,0.05).
On day 4, a probe trial was given in which the animals were
exposed to the pool after the platform had been removed. The
percentage of time that they spent in the target quadrant (vs.
opposite quadrant) was measured as an index of memory
retention. ANOVA indicated significant effects of quadrant
(F1,15=33.78, p,0.01) and treatment (F1,15=6.507, p,0.05) as
well as an interaction between them (F1,15=5.012, p,0.05). As
shown in Figure 4B, plannexin-treated animals spent more time in
the target quadrant than controls, indicating that the peptide
improved memory. No differences in swimming speed were
observed between the two groups (data not shown).
To assess the specificity of the observed effects on spatial
learning and memory, we set up a series of experiments to evaluate
whether the same treatment would influence (i) learning processes
that do not depend on the hippocampus and (ii) general behaviors
related to emotion and locomotion. Thus, a new set of animals was
injected i.c.v. with either plannexin (n=8) or vehicle (n=8)
immediately after training in the auditory fear-conditioning task,
which is known to require the amygdala but not the hippocampus
[31,32]. As shown in Figure 4E, conditioned freezing to the tone
was not affected by plannexin treatment (Mann Whitney,
U14=31.0, n.s.). A second set of animals was tested in both the
EPM and the open-field test after two plannexin vehicle infusions
were administered on the two days preceding the tests. In the
EPM, plannexin influenced neither the percent time spent in the
open arms (vehicle: 6.05%63.48; plannexin: 8.7362.4%; n.s.) nor
the total distance moved (vehicle: 38.5064.6 m; plannexin:
40.7161.8 m; n.s.). In the open field, plannexin affected neither
the animals’ latency to enter the center nor the percent time they
spent in the center of the field (vehicle: 289.2673.06 s and
2.1660.53%; plannexin: 306.8681.9 s and 1.7860.2%, respec-
tively; n.s.)
Because our cell culture experiments showed that plannexin
facilitates neurite outgrowth independently of the presence of PSA-
NCAM, we set up a series of experiments to evaluate whether
plannexin’s facilitating effects on learning and memory could be
observed under conditions of reduced PSA expression. As
confirmed by repeated measures ANOVA, plannexin treatment
of EndoN-infused rats following the same schedule as in former
experiments (i.e., peptide administration immediately after
training on days 1 and 2) partially restored spatial learning in
Endo-N-treated animals to control levels (Figure 5A, main effect of
treatment F2,168=6.65, p,0.01; Bonferroni post-hoc tests: EndoN
vs. control p,0.01; EndoN/plannexin vs. EndoN/control,
p,0.01; EndoN/plannexin vs. vehicle/control, p,0.05). Note
that the lack of effect of Endo N in the first training day is in
agreement with previous studies that showed that the same
treatment affected memory consolidation and retrieval, but not
initial acquisition, in the water maze (Venero et al., 2006). In the
probe test on day 4, all groups swam significantly longer in the
platform quadrant than in the opposite quadrant (main effect of
quadrant F1,24=29.61, p,0.01), but no effect of treatment or
quadrant6treatment interaction was found (n.s.: Figure 5B). Then,
Figure 3. Plannexin enhances synaptic transmission of the Schaffer collateral pathway. A) Bath application of 10 mg/ml (i.e., 1.94 mM)
plannexin increased the slope of the fEPSP evoked by Schaffer collateral stimulation (n=17). B) A scrambled variant of plannexin did not affect the
fEPSP (n=5). C) Plannexin did not modulate the slope of the fEPSPs evoked by perforant pathway stimulation (n=8). D) Summary of A–C, ** p,0.01.
doi:10.1371/journal.pone.0023433.g003
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experimental conditions. EndoN or vehicle was infused 4 days
before animals were sacrificed. EndoN infusion reduced PSA-
NCAM immunoreactivity in the hippocampus to 13.6467.25% of
control levels (Mann Whitney U11=6.0, p,0.01, Figure 5C).
To further confirm that plannexin can improve cognitive
abilities under conditions of impaired PSA-NCAM expression, we
evaluated whether it affected water maze learning in polysialyl-
transferase-1 (PST) KO mice. PST is the predominant enzyme
that catalyzes the attachment of long sialic acid chains to NCAM
in the postnatal brain [33]. As shown in Figure 5D, analysis of the
performance on day 1, before vehicle or plannexin treatment,
confirmed previous evidence of learning impairment in PST mice,
although there was no significant genotype/treatment main effect,
the genotype/treatment6trial interaction was significant
(F6,42=2.24, p,0.05) and only WT group displayed efficient
learning, swimming shorter cumulative distance to the platform on
trial 3 and 4 compared to trial 1 (p,0.05), On day 2 and 3
repeated measures ANOVA confirmed a significant group effect
on learning (F2,42=5.97, p,0.01), with plannexin infusion
restoring PST KO mice performance to WT levels (PST/control
vs. WT/control p,0.01, PST/plannexin vs. PST/control p,0.01
and PST/plannexin vs. WT/control n.s.). However, no differences
among the groups were found for performance in the probe test
(Figure 5E; n.s.), with all groups swimming in the target quadrant
significantly longer than in the opposite quadrant, indicating that
they remembered the location of the platform (p,0.01).
Plannexin increases the percentage of mushroom spines
in the CA1 hippocampal region
Given that plannexin improved hippocampus-related learning
and that electrophysiological experiments indicated that it
potentiates synaptic transmission specifically in the hippocampal
CA1 area, we investigated whether changes in synaptic structure
could be observed in this region under conditions in which
plannexin treatment was found to result in improved memory.
Thus, a 262 experimental design was used to assess the effect of
plannexin treatment on water maze training resulting in four
experimental groups (n=4/group): (i) vehicle: rats were i.c.v.
infused with vehicle over 2 consecutive days and then left
undisturbed until day 4, when animals were sacrificed; (ii)
plannexin: same experimental design as in the previous condition,
but the animals were infused with plannexin; (iii) vehicle+training:
rats were trained for 3 days and injected with vehicle immediately
after their training session on days 1 and 2; they were then
sacrificed on day 4 after the probe test; (iv) plannexin+training: the
same protocol as in the previous condition, except that the
infusions included plannexin. The density of various categories of
spines in these 4 groups are shown in Fig. 6A, together with a
Figure 4. (A) Plannexin i.c.v. infusion immediately after the first and second training session (arrows) improves water maze learning
(A, * p,0.05). (B) In the probe trial on day 3, rats showed better memory retention for the platform location compared to the control group
(* p,0.05). (C) A scramble peptide infused i.c.v. immediately after the first and second training session (arrows) does not alter water maze learning as
compared to vehicle-treated rats. (D) In the probe trial on day 3, rats infused i.c.v with a scramble peptide showed similar memory retention for the
platform location compared to the vehicle group. N=10/group. (E) Plannexin infusion did not affect a hippocampus-independent memory task,
acoustic fear conditioning. No difference was detected in freezing levels between plannexin and control groups during the post-shock period at
training and during tone presentation of the 24 h test. N=8/group. Results are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0023433.g004
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stubby, plus shaft synapses). Figure 6B presents a 3-D reconstruc-
tion of a dendritic segment from over 100 serial ultrathin sections
in CA1 stratum radiatum. Spines were categorized as thin, stubby
and mushrooms spines (see Materials and Methods). A fourth
category comprises synapses in which the presynaptic bouton
contacts the dendrite directly and is termed a ‘shaft’ synapse. A
262 ANOVA indicated a significant effect of plannexin
(F1,12=11.83, p,0.009) on the density of mushroom spines, but
a lack of effect of water maze training (F1,12=0.07, p=0.79) or for
the interaction between the two factors (F1,1=0.25, p=0.63).
Thus, plannexin significantly increased the density of mushroom
spines irrespective of water maze training. Further 262 ANOVAs
performed on synapse density from the other spines categories
failed to show an effect of plannexin or water maze training or
their interaction [but note that a trend towards significance was
found for plannexin treatment to reduce thin synapses
(F1,12=4.57, p=0.065)].
Biochemical plasticity markers following plannexin
treatment in vivo
As with NCAM, the neuritogenic effects of plannexin in vitro
have been shown to be dependent on the activation of the FGFR
[16]. Therefore, we evaluated whether plannexin treatment given
in vivo was capable of activating FGFR1. Rats received an i.c.v.
infusion of either plannexin or vehicle, and brains were dissected
out 40 min after injection. Plannexin treatment was found to
increase FGFR1 phosphorylation in CA1 homogenates compared
to control-injected rats (0.9460.04 and 0.8060.03 arbitrary units,
respectively; t=1.996, df=13, p=0.036).
We also investigated whether plannexin and/or water maze
training induced changes in glutamate receptor expression in the
hippocampus at a time point when the behavioral effects of
plannexin are particularly manifested (i.e., on experimental days
3–4 as shown in Figure 4), and the ultrastructural effects on
different spine categories were also observed (i.e., on experimental
day 4 as shown in Figure 6). Thus, the effect of plannexin
treatment (2.5 mg i.c.v., administered on 2 consecutive days) on the
expression of CA1 hippocampal synaptic AMPAR subunits
(GluA1, GluA2 and GluA3; formerly GluR1, GluR2 and GluR3)
and the GluN1 (formerly NR1) NMDA subunit was examined
under 2 different experimental conditions (n=9 per group): (i)
Untrained: rats were sacrificed 2 days after the last plannexin
injection under basal conditions; (ii) Trained: rats were trained for
3 days and injected immediately after training sessions on days 1
and 2; they were then sacrificed on day 4 immediately after the
Figure 5. (A) Enzymatic removal of PSA-NCAM with EndoN i.c.v. infusion 24 h before training disrupts water maze acquisition on days
2a n d3( p ,0.05), andpost-training (on day 1 and 2)plannexin injection restores the performance ofEndoN pre-treated ratstocontrol
levels (##p,0.01, EndoN/Plannexin vs. EndoN/Control; *p,0.05 EndoN/plannexin vs. Vehicle control; $$p,0.01 EndoN/Control vs
Vehicle Control, N=9/group). (B) In the probe trial on day 3, no significant differences were detected between the three treatment groups. N=9/
group. (C)EndoN induces cleavage of PSA- NCAM in the dentate gyrus. Data are expressed as a percentage of the control group (vehicle-injected),
**p,0.01 versus control group. N=5–6/group. (D) PST mice, showing a genetic deficit in PSA-NCAM expression, are impaired in water maze learning
(
ap,0.05 vs trial 1). Plannexin treatment (arrows) restored water maze learning in PST mice (PST/Control vs. WT/Control ** p,0.01, PST/Plannexin vs PST/
Control ## p,0.01 and PST/Plannexin vs. WT/control n.s.). N=11–17/group. (E) In the probe trial on day 3, no significant differences were detected
between PST and WT littermates or between PST control and PST plannexin-treated subjects. N=10–11/group. Results are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0023433.g005
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animals was observed for any of the glutamate subunits assessed
when they were examined under basal conditions (no training)
(Figure 7A–D). In contrast, plannexin-treated rats submitted to a
probe test on day 4 displayed enhanced synaptic expression of
GluA1 (t=2.77, df=18, p=0.01) and GluA2 (t=2.82, df=16,
p=0.01) in CA1 compared to controls (Figure 7A, B). There was a
trend toward significance for GluA3 (t=2.00, df=16, p=0.06),
Figure 6. (A) Distribution of dendritic spine categories and distribution of synapses according to their spatial localization. The
number of mushroom spines (expressed as synapse density per 100 mm
3) increased significantly after plannexin treatment. (B) An example of a 3D
reconstruction of a dendritic segment. Four categories of synapses are shown. Red color shows postsynaptic densities. Cube=1 mm
3. Results are
expressed as mean 6 SEM. * p,0.05.
doi:10.1371/journal.pone.0023433.g006
Figure 7. Synaptic expression of glutamate receptor subunits after plannexin treatment and water maze training: (A) GluA1
subunit; (B) GluA2 subunit; (C) GluA3 subunit; (D) GluN1B. Rats received 1 daily i.c.v. infusion of either vehicle or plannexin over 2 consecutive
days either under basal conditions (untrained) or immediately after training in the water maze on days 1 and 2 (trained). Hippocampal samples were
taken 2 days after the last drug infusion either under basal conditions (untrained) or following a 3
rd spatial training day and a probe trial just before
sacrifice on day 4 (trained). Data are the mean 6 SEM. *p,0.05 vs. controls. C=Control; P=Plannexin.
doi:10.1371/journal.pone.0023433.g007
NCAM and Cognition Enhancement
PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23433and levels from plannexin-treated rats were lower than controls
following the probe test (Figure 7C). No differences in GluN1
expression between plannexin-treated and control animals were
observed under either of the experimental conditions [untrained
(t=0.30, df=16, p=0.76); trained (t=1.87, df=16, p=0.09),
Figure 7D]. When the total expression of the different receptor
subunits was analyzed in hippocampal homogenates, no differ-
ences were found between plannexin-treated and control groups
(all n.s.; data not shown).
Discussion
NCAM plays a key role in synaptic plasticity [2,34,35] and
cognitive function [9,36,37], suggesting that it may be a
particularly relevant target for which to develop cognition-
enhancing drugs. However, NCAM is a structurally and
functionally complex molecule with multiple domains engaged in
a variety of actions ranging from cell–cell adhesion to cytoplasmic
signaling [14]. These features raise the question as to which
NCAM fragment should be targeted to improve cognition. In this
study, we tested the recently newly synthesized peptide plannexin
that mimics a homophilic trans-binding site in the NCAM Ig2
module (which binds to the NCAM Ig3 module [16]) for its ability
to affect synaptic plasticity and memory formation. We found that
plannexin facilitates neurite outgrowth in primary hippocampal
neuronal cultures and improves spatial learning in rats, both under
basal conditions and under reduced PSA-NCAM. The effect on
spatial learning seems to be quite specific because plannexin affects
neither hippocampus-independent learning, auditory fear condi-
tioning (however, a note of caution should be added since recent
work indicates that the amygdala’s involvement in auditory fear
conditioning takes place during acquisition, not consolidation, of
information [38], and the present study only involved post-training
peptide injections), nor emotional or locomotor responses to
novelty. We also found that plannexin enhances hippocampal
FGFR1 phosphorylation and synaptic transmission in CA1 (but
not in the dentate gyrus), where it also increases the number of
mushroom spines and the synaptic expression of the AMPAR
subunits GluA1 and GluA2. Altogether, these results highlight
plannexin as an important modulator of hippocampus-dependent
cognition and synaptic plasticity.
Plannexin was previously shown by surface plasmon resonance
analysis to bind the NCAM Ig3 module and to induce neurite
outgrowth in primary cultures of CGNs and dopaminergic
neurons in an NCAM-dependent manner [16]. Here, we extend
these findings to primary hippocampal cultures. We show that the
magnitude of the effect is comparable to that in CGN cultures, and
in both cases, the effect is independent of PSA-NCAM.
Importantly, we show that plannexin improves long-term spatial
memory when injected icv in rats using a regimen of infusions (ie,
treatment was given immediately after water maze training on
days 1 and 2) previously proven to be effective for another
NCAM-related peptide, FGL, which binds and activates FGFR
[11]. The critical role of PSA-NCAM in synaptic plasticity and
memory is well established in the literature [34,35,39–42].
Plannexin also improves learning and memory in PSA-NCAM-
deficient animals: both in rats infused with the enzyme EndoN and
in PST KO mice, which show reduced PSA-NCAM expression in
the adult forebrain [40,43] and deficiencies in learning during
training days 2 and 3. This indicates again that plannexin’s effect is
independent of PSA-NCAM expression, and it underscores
plannexin as an effective treatment for cognitive deficits associated
with PSA-NCAM deficiency, a condition reported to accompany,
for example, aging [44,45].
When hippocampal slices were examined, synaptic transmission
from Schaffer collaterals to CA1 pyramidal cells, but not at the
perforant path synapses in the dentate gyrus, was potentiated
following acute plannexin treatment. This rapid effect was
paralleled by our in vivo data showing increased FGFR
phosphorylation in the hippocampus 40 min after icv plannexin
infusion. This activation of FGFR supports the view that
plannexin effects include a previously well characterized pathway
for NCAM actions in neural plasticity [46,47]. These data agree
well with former work in cell cultures showing that plannexin-
induced neurite outgrowth is dependent on FGFR activation [16].
NCAM-mediated signaling includes direct binding to and
activation of FGFR [48]. Importantly, plannexin was found to
activate FGFR via its binding to NCAM [16], which differs from
the mechanisms of action of the FGL peptide, whose plasticity-
inducing and cognitive-enhancing effects are not dependent on the
presence of NCAM [10,48]. The absence of an effect of plannexin
at the perforant pathway suggests that plannexin could affect
NCAM/FGFR signaling differentially across synaptic populations.
Indeed, different expression of the FGFR receptor subtypes across
hippocampal subfields, specifically the absence of FGFR-2 and 3
mRNA in the dentate gyrus, has been documented [49].
Furthermore, that polysialylation of hippocampal NCAM persists
into the adulthood particularly in the dentate gyrus [50]. This
could suggest a dependence of acute plannexin effects to
polysialylation although its long-term effects on neurite outgrowth
observed here were insensitive to polysialylation.
In the CA1 stratum radiatum, plannexin-treated animals showed
an increase in the percentage of mushroom spines when analyzed
2 days after the last peptide treatment. This time point was
selected to coincide with the period at which facilitating effects of
the peptide are evident (Figure 4). Interestingly, the effect of
plannexin was detected in both water maze-trained and untrained
animals, indicating that the observed structural changes do not
require synergy between the peptide’s actions and training-
triggered activity. This is at odds with the enhanced synaptic
expression of GluA1 and GluA2 subunits observed in the CA1
region in water maze-trained plannexin-treated animals but not in
untrained ones. There are different interpretations of these data.
The group simultaneously subjected to drug and training regimens
has the ability to selectively drive these AMPAR subunits to the
synaptic compartment (note that there were no changes in their
total expression levels in homogenates); or this putative effect of
plannexin does not require a history of prior training, but is
triggered by the probe test given to trained animals in this
experimental group just before samples are collected. The latter
possibility seems the most plausible according to our unpublished
experiments, in which we observed no changes in the levels of the
different glutamate receptor subunits in a group of animals that
followed the same treatment as in the present study except that
samples were collected on day 4 under basal conditions following a
probe test.
Plannexin treatment might, therefore, affect mechanisms in-
volvedinthesynaptictrafficking ofAMPAR subunits. Furthermore,
it may be capable of driving GluA1 and GluA2 to the synaptic
compartment under conditions of circuit stimulation, such as those
induced by spatial testing in the water maze. The link of such a
mechanismwiththe improvement inlearningand memory foundin
plannexin-treated animals is strongly supported by a large body of
data linking synaptic expression of these AMPAR subunits with
facilitated synaptic plasticity [51–55] and memory [27,53,56,57].
An important prediction derived from these data is that, given the
appropriate behavioral stimulation 2 days after the last peptide
infusion, animals in the plannexin-treated untrained group should
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as well as facilitated learning capabilities. This will be evaluated in
future studies aimed at understanding the specific temporal and
experimental dynamics required for plannexin’s cognitive-enhanc-
ing properties. Although links between NCAM, AMPAR [58,59]
and NMDAR [60] function have only recently begun to be
uncovered, early indirect observations also support this connection.
NCAM-induced neurite outgrowth involves activation of both
FGFR and Fyn,a member ofthe Src-family,asshown forplannexin
in vitro [16]. Both signaling cascades have been shown, indepen-
dently, to affect the expression of AMPARs [61,62].
As to the structural changes observed, plannexin induced an
increase in the number of mushroom spines, which have been
called ‘memory’ spines [63,64]. They are more stable over time
than spines with small heads, and they normally show enhanced
PSD complexity and/or dimensions after physiological stimulation
[63,64], as observed in our plannexin-treated animals. The PSDs
of these spines normally contain a higher density of glutamate
receptors, which also fits with the enhanced AMPAR expression
induced by plannexin treatment in trained animals. In fact, the
GluA2 subunit was shown to play a crucial role in the formation
and growth of dendritic spines in cultured hippocampal neurons
and to interact with the cell adhesion molecule N-cadherin to
produce this effect [65]. Importantly, evidence was also presented
that GluA2-containing receptors contribute to features of
mushroom spines, with GluR2 KO mice showing lower numbers
of synapses on mushroom spines and significant decreases in the
volume and surface area of mushroom spines and their PSDs [66].
In addition, our ultrastructural observations also confirmed typical
features of these mushroom spines, such as their higher endosome
content [64]. The morphological changes induced by plannexin
largely resemble those previously found after LTP induction both
in vitro [67,68] and in vivo [69,70]. Interestingly, chronic
treatment with the NCAM mimetic peptide FGL for 2.5 weeks
in aged rats also leads to an increased proportion of mushroom
spines [71]. Altogether, the reported morphological and biochem-
ical findings are important because they show that plannexin
treatment provides structural and molecular changes correlated
with enhanced synaptic strength [72]. A strong memory is believed
to require lasting morphological changes that increase the strength
of the synapses encoding information related to memory and that
increase the size of spine heads to accommodate more glutamate
receptors [72,73].
Altogether, this study presents compelling evidence that
plannexin is an important facilitator of synaptic functional,
structural and molecular plasticity in the hippocampal CA1
region, highlighting the fragment in NCAM’s Ig3 module where
plannexin binds as a novel target for the development of cognition-
enhancing drugs.
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